Front & Back Matter.
- Published in:
- Pharmacology, 2025, v. 110, n. 1, p. 1, doi. 10.1159/000544015
- Publication type:
- Article
Works matching IS 00317012 AND DT 2025 AND VI 110 AND IP 1
Results: 8
1
2
Retraction Statement.
- Published in:
- Pharmacology, 2025, v. 110, n. 1, p. 62, doi. 10.1159/000542299
- Publication type:
- Article
3
Traditional Chinese Medicine Monomers Are Potential Candidate Drugs for Cancer-Induced Cardiac Cachexia.
- Published in:
- Pharmacology, 2025, v. 110, n. 1, p. 49, doi. 10.1159/000540915
- By:
- Publication type:
- Article
4
Erratum.
- Published in:
- 2025
- Publication type:
- Correction Notice
5
Preclinical Evaluation of Sodium Butyrate's Potential to Reduce Alcohol Consumption: A Dose-Escalation Study in C57BL/6J Mice in Antibiotic-Enhanced Binge-Like Drinking Model.
- Published in:
- Pharmacology, 2025, v. 110, n. 1, p. 36, doi. 10.1159/000540882
- By:
- Publication type:
- Article
6
Semaglutide Ameliorates Hepatocyte Steatosis in a Cell Co-Culture System by Downregulating the IRE1α-XBP1-C/EBPα Signaling Pathway in Macrophages.
- Published in:
- Pharmacology, 2025, v. 110, n. 1, p. 26, doi. 10.1159/000540654
- By:
- Publication type:
- Article
7
Drug-Drug Interactions in Hospitalized Urological Patients: A Retrospective Cohort Study.
- Published in:
- Pharmacology, 2025, v. 110, n. 1, p. 15, doi. 10.1159/000540427
- By:
- Publication type:
- Article
8
Early Use of PCSK9 Inhibitors in the Prognosis of Patients with Acute Coronary Syndrome by Protecting Vascular Endothelial Function.
- Published in:
- Pharmacology, 2025, v. 110, n. 1, p. 1, doi. 10.1159/000540083
- By:
- Publication type:
- Article